Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Viral Immunology|October 28, 2015
Impact of OAS1 Exon 7 rs10774671 Genetic Variation on Liver Fibrosis Progression in Egyptian HCV Genotype 4 PatientsNoha G Bader El Din, Mohamed A Anany, Reham M Dawood, et al.
Cancer Cell International|June 29, 2006
Antisense oligonucleotide inhibition of hepatitis C virus genotype 4 replication in HepG2 cellsMostafa K el-Awady, Noha G Badr el-Din, Wael T el-Garf, et al.
World Journal of Hepatology|April 5, 2013
Association between low molecular polypeptide 7 single nucleotide polymorphism and response to therapy in hepatitis C virus infectionMoataza H Omran, Basma E Fotouh, Samar S Youssef, et al.
Clinical Laboratory|February 7, 2017
Level of Human Antibodies Targeting HCV E1/E2 Peptides and Spontaneous Clearance of HCV in Blood DonorsAshraf A Tabll, Eman A Salem, Yasmine S El-Abd, et al.
Microbial Pathogenesis|February 20, 2021
Development of a gene signature for predicting cirrhosis risk score of chronic liver disease associated with HCV infection in EgyptiansReham M Dawood, Ghada M Salum, Mai Abd El-Meguid, et al.
BMC Infectious Diseases|November 7, 2019
A multiepitope peptide vaccine against HCV stimulates neutralizing humoral and persistent cellular responses in miceReham M Dawood, Rehab I Moustafa, Tawfeek H Abdelhafez, et al.
World Journal of Gastroenterology|January 25, 2013
IL28B polymorphism and cytomegalovirus predict response to treatment in Egyptian HCV type 4 patientsMostafa K El Awady, Noha G Bader El Din, Ashraf Tabll, et al.
Viral Immunology|February 3, 2017
The Synergistic Effect of TNFα -308 G/A and TGFβ1 -509 C/T Polymorphisms on Hepatic Fibrosis Progression in Hepatitis C Virus Genotype 4 PatientsNoha G Bader El Din, Sally Farouk, Reem El-Shenawy, et al.
Virus Research|January 4, 2011
WITHDRAWN: Caprine antibodies towards E2 conserved peptides interfere with hepatitis C virus infectivity in vitroYasmine S Elabd, Ashraf A Tabll, Noha G Bader El Din, et al.
Human Antibodies|October 18, 2017
Neutralizing activity and safety of human monoclonal antibodies against hepatitis C virusCamelia A Abdel Malak, Tawfeek H Abelhafez, Ashraf A Tabll, et al.
Pageof 7